Can a new drug boost Semaglutide's power against diabetes and obesity?
Disease control
Recruiting now
This phase 2 trial tests whether adding an experimental drug called AT673 to the standard diabetes medication semaglutide leads to greater weight loss and better blood sugar control in adults with type 2 diabetes who are overweight or obese. Participants receive either a low or h…
Phase: PHASE2 • Sponsor: Antag Therapeutics • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC